State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT06088290 Phase 3
Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone ...
Condition
Leiomyosarcoma
Enrollment
450 pts
Location
United States, Austria, Belgium
Sponsor
PharmaMar
NCT05184660 N/A
Recruiting
Smart Eyewear to Automatically Detect Drug Delivery Events
Condition
Smart Eyewear
Enrollment
20 pts
Location
United States
Sponsor
University of Washington
NCT04620239 Phase 3
Recruiting
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTE...
Condition
Transitional Cell Cancer of Renal Pelvis and Ureter
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Steba Biotech S.A.
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT06526819 Phase 1, Phase 2
Recruiting
SMP-3124LP in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
120 pts
Location
United States, Japan
Sponsor
Sumitomo Pharma America, Inc.
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
NCT06885034 Phase 1, Phase 2
Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other ...
Condition
Gastrointestinal Neoplasms
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06232304 N/A
Recruiting
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythemato...
Condition
Systemic Lupus Erythematosus of Childhood (Disorder)
Enrollment
175 pts
Location
United States, Canada
Sponsor
Michigan State University
NCT03511118 N/A
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breast...
Condition
Lactating Women on Select DOI
Enrollment
1,600 pts
Location
United States, Canada
Sponsor
Duke University
NCT05879835 N/A
Recruiting
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With...
Condition
Pediatric Intestinal Failure
Enrollment
124 pts
Location
United States
Sponsor
SterileCare Inc.
NCT05989568 N/A
Recruiting
BASIS-T Efficacy Trial
Condition
Behavior, Child
Enrollment
276 pts
Location
United States
Sponsor
University of Washington
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT07396584 Phase 1, Phase 2
Recruiting
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
Condition
Solid Tumors, Adult
Enrollment
186 pts
Location
United States, China
Sponsor
Hutchmed
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT06313515 N/A
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular...
Condition
Spinal Cord Injuries
Enrollment
16 pts
Location
United States
Sponsor
University of Washington
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06540859 N/A
Recruiting
Spinal Cord Stimulation for Autonomic Recovery in Inpatient Rehabilitation After...
Condition
Spinal Cord Injuries
Enrollment
26 pts
Location
United States
Sponsor
University of Washington
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04239703 N/A
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
Condition
Kidney Transplant Rejection
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT05010603 N/A
Recruiting
Late Onset Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Columbia University
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT05135403 N/A
Recruiting
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Condition
Sudden Cardiac Arrest
Enrollment
5,179 pts
Location
United States
Sponsor
Kestra Medical Technologies, I